Legend Biotechcorp Stock Investor Sentiment
| LEGN Stock | USD 45.17 2.28 4.81% |
About 64% of Legend BiotechCorp's investor base is looking to short. The analysis of the overall investor sentiment regarding Legend BiotechCorp suggests that many traders are alarmed. Legend BiotechCorp's investor sentiment overview provides quick insight into current market opportunities from investing in Legend BiotechCorp. The current market sentiment, together with Legend BiotechCorp's historical and current headlines, can help investors time the market. In addition, many technical investors use Legend BiotechCorp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
36
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Legend BiotechCorp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Legend BiotechCorp.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Legend BiotechCorp stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Legend daily returns and investor perception about the current price of Legend BiotechCorp as well as its diversification or hedging effects on your existing portfolios.
Legend Historical Sentiment
Although Legend BiotechCorp's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Legend, such as negative comments on social media and news outlets, may cause fear in the market and push Legend BiotechCorp's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Legend.
Legend |
Legend BiotechCorp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Legend BiotechCorp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Legend BiotechCorp Historical Investor Sentiment
Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp news discussions. The higher the estimate score, the more favorable the investor's outlook on Legend BiotechCorp.
Legend BiotechCorp Maximum Pain Price across 2024-05-17 Option Contracts
Legend BiotechCorp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Legend BiotechCorp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Legend BiotechCorp's options.
Far too much social signal, news, headlines, and media speculation about Legend BiotechCorp that are available to investors today. That information is available publicly through Legend media outlets and privately through word of mouth or via Legend internal channels. However, regardless of the origin, that massive amount of Legend data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Legend BiotechCorp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Legend BiotechCorp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Legend BiotechCorp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Legend BiotechCorp alpha.
Legend BiotechCorp Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights - The Globe and Mail | 02/29/2024 |
2 | CARVYKTI Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with RelapsedRefractory Multiple Myeloma | 03/15/2024 |
3 | FDA Adcomm Favors Expanded Use Of Johnson Johnson, Bristol Myers CAR-T Therapies For Type Of Blood Cancer | 03/18/2024 |
4 | Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance Report | 03/19/2024 |
5 | GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy | 03/20/2024 |
6 | HC Wainwright Reiterates Buy Rating for Legend Biotech - Defense World | 04/02/2024 |
7 | Johnson Johnsons Carvykti Stands Ahead Of Bristol Myers Rival Blood Cancer Therapy With FDA Approval For Wider Population | 04/08/2024 |
8 | Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results | 04/11/2024 |
9 | FDA Mandates Boxed Warning For Bristol Myers, Johnson Johnson CAR-T-Based Blood Cancer Therapies | 04/19/2024 |
10 | CARVYKTI Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma | 04/22/2024 |
Check out Legend BiotechCorp Hype Analysis, Legend BiotechCorp Correlation and Legend BiotechCorp Performance. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.